Results 81 to 90 of about 1,873,801 (260)

P1340: RESPONSE RATES AND PROGNOSTIC FACTORS IN ACUTE GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE

open access: yesHemaSphere, 2022
J. Freitas   +7 more
doaj   +1 more source

Human placenta-derived endothelial progenitor cells: an animal-free culture system for efficient expansion

open access: yesBiological Research
Background Endothelial progenitor cells (EPCs) play a critical role in vasculogenesis and vascular repair, but their clinical application is hindered by challenges such as cell purity, quantity, and reliance on fetal bovine serum (FBS).
Shengnan Yuan   +7 more
doaj   +1 more source

Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation

open access: yes, 2001
Twenty-three children with de novo acute myelogenous leukemia (AML) (n = 20), secondary AML (n = 1), or non-Hodgkin's lymphoma (NHL) (n = 2) underwent allogeneic bone marrow transplantation (alloBMT) for graft failure (n = 1) or recurrent malignancy (n =
Cunningham, J. M.   +23 more
core   +1 more source

3D‐Printed Titanium Gyroid Scaffold Structure Integrated With Tough Hybrid Materials for Cartilage Replacement

open access: yesAdvanced Engineering Materials, EarlyView.
This study proposes a potential device design for joint cartilage replacement. Silica‐polytetrahydrofuran (SiO2‐PolyTHF) hybrids with customizable mechanical properties were developed to mimic the characteristics of a natural meniscus. These were synthesized through a two‐pot sol–gel hybrid process.
Yu‐Chien Lin   +12 more
wiley   +1 more source

P887: IN-HOUSE ANTI BCMA CAR-T THERAPY FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA: PHASE 1 RESULTS.

open access: yesHemaSphere, 2022
N. Asherie   +9 more
doaj   +1 more source

Promyelocyte in bone marrow smear (human)

open access: yes, 2007
Stain: May-Grnwald-Giemsa (MGG). The promyelocyte is the largest cell in the myeloid series in bone marrow. The nucleus is still transparent with fine chromatin and nucleoli are well visible.
Poels, Lambert G.
core  

A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita

open access: yes, 2012
[No abstract available]Ayas M, 2007, PEDIATR BLOOD CANCER, V49, P103, DOI 10.1002-pbc.20696; Bacigalupo A, 2010, HAEMATOL-HEMATOL J, V95, P976, DOI 10.3324-haematol.2009.018267; Dietz AC, 2011, BONE MARROW TRANSPL, V46, P98, DOI 10.1038-bmt.2010.65; Dror
Bacigalupo A.   +5 more
core   +1 more source

Biodegradable and Biocompatible Functional Polymers for Biomedical Applications

open access: yesAdvanced Functional Materials, EarlyView.
Biodegradable and biocompatible functional polymers integrate electrical, mechanical, and stimuli‐responsive functionalities while enabling programmed degradation under physiological conditions. This review introduces recent advances in conductive, shape‐memory, self‐healing, photocurable, and adhesive polymer systems, emphasizing material design ...
Won Bae Han   +5 more
wiley   +1 more source

Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement

open access: yesAnnals of Hematology
Relapse of acute myeloid leukemia with CBFB::MYH11 fusion and KIT D816V mutation after allogeneic hematopoietic stem cell transplantation is uncommon and often associated with aggressive extramedullary spread and poor outcomes, particularly when the ...
Marco Frigeni   +9 more
doaj   +1 more source

A focus on LBCL patients in partial remission in the CAR-T era

open access: yesFrontiers in Hematology
The treatment paradigm for large B-cell lymphoma (LBCL) has undergone significant changes in recent years. Patients who fail to achieve a complete response (CR) after first-line therapy (1L) or relapse within 12 months are considered to have a poor ...
Giuseppe Tarantini   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy